Cheapest Tirzepatide Providers in 2026 — Ranked & Reviewed
Tirzepatide is the most effective GLP-1 weight loss medication, but retail prices can hit $1,000+/month. We ranked every legitimate telehealth provider offering tirzepatide by their lowest published monthly cost for 2026 — so you can find a real, affordable option without falling for hidden-fee pricing.
Lowest verified price: $69/mo448 providers compared
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
448 cheapest tirzepatide providers compared · independently scored against our six-factor methodology.
Compare the top providers at a glance
Logos, our editorial rating, price, medications, and coverage — the fastest way to narrow the list.
- ★ Editor's Pick
the lowest flat medication price if you can absorb an annual membership fee
From /mo$69Flat at every doseCoverageCheck intakeMedicationsSemaglutideTirzepatide - Best Budget
mainstream telehealth GLP-1 access
From /mo$99Coverage50 statesMedicationsSemaglutideTirzepatide - Nationwide Coverage
brand Wegovy, Zepbound or Ozempic access alongside cheaper compounded GLP-1
From /mo$99Flat at every doseCoverage50 statesMedicationsSemaglutideTirzepatide switching between compounded and brand-name GLP-1 through one provider
From /mo$99Coverage48 statesMedicationsSemaglutideTirzepatideevery commitment tier priced openly, plus a low-dose microdose option
From /mo$119Flat at every doseCoverageCheck intakeMedicationsSemaglutideTirzepatidecompounded semaglutide and tirzepatide at a flat lifetime price
From /mo$119Flat at every doseCoverageCheck intakeMedicationsSemaglutideTirzepatidebudget-conscious shoppers
From /mo$125Flat at every doseCoverage50 statesMedicationsSemaglutideTirzepatidelow flat-rate compounded GLP-1 pricing at every dose
From /mo$129Coverage50 statesMedicationsSemaglutideTirzepatide
| Provider | Rating | From /mo | Medications | Coverage | |
|---|---|---|---|---|---|
★ Editor's Pick the lowest flat medication price if you can absorb an annual membership fee | $69 Flat pricing | SemaglutideTirzepatide | Check intake | Visit → | |
Best Budget mainstream telehealth GLP-1 access | $99 | SemaglutideTirzepatide | 50 states | Visit → | |
Nationwide Coverage brand Wegovy, Zepbound or Ozempic access alongside cheaper compounded GLP-1 | $99 Flat pricing | SemaglutideTirzepatide | 50 states | Visit → | |
 switching between compounded and brand-name GLP-1 through one provider | $99 | SemaglutideTirzepatide | 48 states | Visit → | |
 every commitment tier priced openly, plus a low-dose microdose option | $119 Flat pricing | SemaglutideTirzepatide | Check intake | Visit → | |
 compounded semaglutide and tirzepatide at a flat lifetime price | $119 Flat pricing | SemaglutideTirzepatide | Check intake | Visit → | |
 budget-conscious shoppers | $125 Flat pricing | SemaglutideTirzepatide | 50 states | Visit → | |
 low flat-rate compounded GLP-1 pricing at every dose | $129 | SemaglutideTirzepatide | 50 states | Visit → |
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
Detailed Reviews
Collective
Verified partnerBest for: the lowest flat medication price if you can absorb an annual membership fee
Collective (collective.org) is a membership-based telehealth platform from the founder of Thrive Market, selling compounded semaglutide and tirzepatide at a flat price on every dose. Medication is billed separately from a required annual membership, and the program bundles unlimited clinician messaging, dietitian access and express cold shipping.
Score Breakdown
Pros
- ✓The lowest published compounded GLP-1 medication prices we track — $59/month semaglutide and $69/month tirzepatide
- ✓Flat pricing at every dose, so titrating up does not raise the bill
- ✓Unlimited clinician messaging and registered-dietitian access are included rather than upsold
- ✓21-day free trial on the membership before the annual fee is charged
Cons
- ✗The advertised $59 and $69 exclude a mandatory $199 annual membership — the real first-year cost is $907 and $1,027
- ✗Membership fees are non-refundable and no partial-period refunds are given
- ✗Compounding pharmacies are described only as 'independent, third-party licensed pharmacies' and are never named
- ✗State availability is not published on the marketing site
Found
Verified partnerBest for: mainstream telehealth GLP-1 access
Personalized weight care platform with a self-pay membership model plus medication costs.
Score Breakdown
Pros
- ✓Aggressively low monthly pricing
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
Cons
- ✗Limited public information on program details
MEDGm
Verified partnerBest for: brand Wegovy, Zepbound or Ozempic access alongside cheaper compounded GLP-1
MEDGm is a Delaware telehealth platform selling compounded semaglutide injections at $299/mo, compounded tirzepatide injections at $399/mo and a daily dissolvable semaglutide tablet at $369/mo, with care delivered by OpenLoop Health providers and four named US compounding pharmacies. Every product page prints the full month-to-month and 3-, 6- and 12-month ladder and charges the same price at any dose. Brand Wegovy, Zepbound and Ozempic are sold as a membership fee ($99-$171/mo) plus the drug's own cost. Cash-pay only.
Score Breakdown
Pros
- ✓Compounded semaglutide injections at $299/mo with medication, clinician access and shipping in one price
- ✓A daily dissolvable semaglutide tablet for people who do not want to inject, at $369/mo
- ✓Names the molecule on every compounded product page and prints the full 3-, 6- and 12-month price ladder publicly
- ✓Every product page states 'Same price, any dose', so titrating up does not raise the bill
- ✓Brand Wegovy, Zepbound and Ozempic available on a membership-plus-medication basis
- ✓Four named US pharmacy partners with addresses (RedRock, Health Warehouse, Precision Medicine, Triad Rx)
- ✓Clinical care through the OpenLoop Health provider network; service listed in all 50 states and DC
- ✓Published support line and email, with a 24/7 patient support line described in the refund policy
Cons
- ✗No dose ladder is published — the site never says which milligram strength you start on or how it steps up
- ✗You pay before a clinician reviews you — the Terms say the consult happens after the fee is charged
- ✗The plan fee is billed upfront for the whole term and is non-refundable, except for a documented medical disqualification
- ✗Canceling a 3-, 6- or 12-month bundle mid-term refunds nothing; you must give notice 72 hours before renewal
- ✗The 'starting at' figures are 12-month prepay equivalents; month-to-month is $299 for the injection and $369 for the tablet
- ✗A Trustpilot five-star badge runs in the quiz, but the Trustpilot profile shows 0 reviews and a 0.0 rating
- ✗Site disclaimers state that images and other content may be AI-generated and that people in ads may be actors or AI
- ✗Compounded GLP-1s are not FDA-approved
MEDVi
Verified partnerBest for: switching between compounded and brand-name GLP-1 through one provider
MEDVi is a telehealth weight-loss platform offering compounded GLP-1 injections and tablets (semaglutide) as well as brand-name Wegovy and Zepbound through licensed US pharmacies. Medical treatment is delivered by OpenLoop Health clinicians and CareGLP Affiliated P.C.s.
Score Breakdown
Pros
- ✓Both compounded and brand-name (Wegovy, Zepbound) GLP-1 options in one platform
- ✓Oral tablet and injectable formats
- ✓Named US pharmacy partners (Triad Rx, Precision Medicine, RedRock Pharmacy, Beaker Pharmacy & Compounding)
- ✓Clinical oversight through OpenLoop Health provider network and CareGLP Affiliated P.C.s
- ✓Direct-to-home shipping with 24/7 support
Cons
- ✗Refill price for compounded GLP-1 injection ($299) steps up significantly from $179 first-month offer
- ✗Not available in Mississippi or North Dakota (telehealth regulation constraints)
- ✗Alabama and California patients can only receive injectable formats, not tablets, per state law
- ✗Kansas, Indiana, New Mexico, Oklahoma, and West Virginia require a synchronous provider visit before prescribing
- ✗No LegitScript or PCAB certification disclosed on the site
Lttl
Verified partnerBest for: every commitment tier priced openly, plus a low-dose microdose option
Lttl (pronounced 'little') is a direct-to-consumer telehealth brand offering compounded semaglutide and tirzepatide, a low-dose 'microdose' line, and longevity peptides. It publishes its full price matrix — every medication and commitment length — before checkout, and bills one flat rate regardless of dose. Month-to-month compounded semaglutide is $99/mo and tirzepatide $149/mo, with lower per-month rates on 3-, 6- and 12-month prepay plans.
Score Breakdown
Pros
- ✓Publishes the full price matrix — every medication, form and commitment length — on a public /plans page before checkout
- ✓Flat dose pricing: 'Same price at every dose,' so moving to a higher dose does not raise the monthly bill
- ✓States plainly that its compounded GLP-1s 'are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality'
- ✓Microdose line prices low-dose semaglutide or tirzepatide at $149/mo month-to-month for people sensitive to side effects
- ✓Cancel anytime with no contract, from the account portal or by email
- ✓Free shipping with cold-chain packaging and tracking; HSA and FSA funds accepted
Cons
- ✗Partner pharmacies are never named — the site refers only to 'a partner U.S. pharmacy' (a material disclosure gap for a YMYL purchase)
- ✗The advertised 'Plans start at $139/mo' is the annual prepay rate; true month-to-month is $99 semaglutide and $149 tirzepatide
- ✗No public list of states served — eligibility depends on where unnamed 'partner providers are licensed'
- ✗Banner says 'Prescribed and shipped within 48 hours'; the shipping policy says 2-5 business days to process plus 3-7 to deliver
- ✗Orders are non-refundable once the initial medical intake is submitted; refund requests must be emailed within 28 days
- ✗Does not bill insurance; consultation and medication are entirely out of pocket
- ✗Terms impose mandatory individual arbitration and waive class actions
- ✗Claims 'Lttl is LegitScript Certified' on /about-us, but the seal links to a lookup form rather than to a certificate
How to find the cheapest legitimate tirzepatide
Compounded tirzepatide can be far cheaper than brand-name Zepbound — but the cheapest listing isn't automatically the best. Here's how to compare honestly.
What to look for
- Compare the real monthly total. Sort by the ongoing per-month price including membership, not the intro offer. A '$99 first month' can become $300+ ongoing.
- Longer plans win on price, lose on flexibility. 12-month plans post the lowest per-month numbers but require commitment. Balance the savings against not knowing yet how you'll tolerate the medication.
- Never trade safety for price. A rock-bottom price with no named pharmacy or LegitScript listing isn't a deal — it's an unknown. Keep the trust score in view.
Red flags to avoid
- No named pharmacy or LegitScript listing. A legitimate compounded-GLP-1 provider names its 503A/503B pharmacy partner and carries LegitScript certification. If neither is disclosed, you can't verify what you're injecting.
- Async-only, no real clinician review. A prescriber should review your intake and be reachable for dose questions. Instant approval with no way to reach a clinician is a safety gap.
- Teaser pricing that hides the real cost. A low 'first month' price that jumps at higher doses, or a membership fee stacked on top of the medication, can double the true monthly total. Confirm the ongoing, all-in price before you pay.
- Weight-loss claims for B12, MIC, or HCG shots. Only GLP-1 injections have trial evidence for weight loss. A clinic selling B12, lipotropic, or HCG shots as a weight-loss treatment is a red flag.
Every provider ranked above is scored against these criteria across our six-dimension methodology, and prices are re-verified against each provider’s live site.
How we rank & what counts as “legit”
Every provider in this ranking is scored against our published six-factor rubric[1] — value, effectiveness, user experience, trust & safety, accessibility, and support.
Brand-name Wegovy, Zepbound, Ozempic, and Mounjaro are separately FDA-approved under their own NDA numbers[4][5]. Published Phase 3 efficacy for semaglutide 2.4 mg (~14.9% mean weight loss over 68 weeks) comes from the STEP 1 trial[6], and for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) from SURMOUNT-1[7]; the SURMOUNT-5 head-to-head published in 2025 compared the two directly[8].
Insurance coverage for anti-obesity medications varies widely by state Medicaid program and commercial plan[9][10]. Compounded and brand-name GLP-1s are generally FSA/HSA eligible with a prescription under IRS Publication 502[11].
Frequently Asked Questions
Sources & methodology — as of October 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
- 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
- 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.